Dr Sikhulile Moyo, a laboratory manager at a medical research institute in Botswana, completed his undergraduate at the University of Zimbabwe before moving to Botswana where he is now lead virologist ay the Botswana Harvard Partnership (BHP).
Dr Houriiyah Tegally, a Mauritian epidemiologist based in South Africa, acknowledged the role played by Dr Moyo but feared that the global community would still discriminate people from countries that have shared such phenomenal research.
“I want to acknowledge our Botswana colleagues under the leadership of Sikhulile Moyo who were the first actually to sequence this variant. They’ve conducted amazing genomic surveillance in Africa so far and have had some of the fastest turnaround times for sequencing.
“Unfortunately, their good science will also be rewarded with discrimination from much of the global community,” she said.
A native of Zimbabwe, Dr Moyo moved to Botswana after completing his undergraduate degree at the University of Zimbabwe, Harare in 1996.
He started working at the Botswana Harvard Partnership as a Laboratory Assistant in 2003 and rose through the ranks to his current position as Laboratory Manager.
He holds Master’s degrees in Applied Microbiology and Public Health and is to soon complete his PhD in Medical Virology from Stellenbosch University, South Africa.
For his thesis, “Evolutionary trends and dynamics of HIV-1C in Botswana,” he used new molecular and serological methods to identify and characterize early founder viruses. And, yes, the samples for his research came from the BHP freezers.
Moyo is happily married and has two sons and a daughter. He and his wife sponsor several children, both relatives and non-relatives, at a school each year. He loves singing, composes gospel songs, and is recording his second album.
“I wake up daily inching towards pursuing my goals with vigor and relentless commitment,” said Moyo. “Working with scientists and mentors at BHP has made me realize that every moment is a great moment for action.”